Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

NsrR targets in the Escherichia coli genome: new insights into DNA sequence requirements for binding and a role for NsrR in the regulation of motility.

Partridge JD, Bodenmiller DM, Humphrys MS, Spiro S.

Mol Microbiol. 2009 Aug;73(4):680-94. doi: 10.1111/j.1365-2958.2009.06799.x. Epub 2009 Jul 27.

2.

Escherichia coli NsrR regulates a pathway for the oxidation of 3-nitrotyramine to 4-hydroxy-3-nitrophenylacetate.

Rankin LD, Bodenmiller DM, Partridge JD, Nishino SF, Spain JC, Spiro S.

J Bacteriol. 2008 Sep;190(18):6170-7. doi: 10.1128/JB.00508-08. Epub 2008 Jul 25.

3.
4.

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides.

Benson MD, Kluve-Beckerman B, Zeldenrust SR, Siesky AM, Bodenmiller DM, Showalter AD, Sloop KW.

Muscle Nerve. 2006 May;33(5):609-18.

PMID:
16421881
5.

Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.

Watts LM, Manchem VP, Leedom TA, Rivard AL, McKay RA, Bao D, Neroladakis T, Monia BP, Bodenmiller DM, Cao JX, Zhang HY, Cox AL, Jacobs SJ, Michael MD, Sloop KW, Bhanot S.

Diabetes. 2005 Jun;54(6):1846-53.

6.

Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.

Sloop KW, Cao JX, Siesky AM, Zhang HY, Bodenmiller DM, Cox AL, Jacobs SJ, Moyers JS, Owens RA, Showalter AD, Brenner MB, Raap A, Gromada J, Berridge BR, Monteith DK, Porksen N, McKay RA, Monia BP, Bhanot S, Watts LM, Michael MD.

J Clin Invest. 2004 Jun;113(11):1571-81.

8.

Novel strategy yields candidate Gsh-1 homeobox gene targets using hypothalamus progenitor cell lines.

Li H, Schrick JJ, Fewell GD, MacFarland KL, Witte DP, Bodenmiller DM, Hsieh-Li HM, Su CY, Potter SS.

Dev Biol. 1999 Jul 1;211(1):64-76.

Supplemental Content

Loading ...
Support Center